-
Product Insights
NewLikelihood of Approval Analysis for Hepatitis B
Overview How likely is it that the drugs in Hepatitis B will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hepatitis B Overview Hepatitis B, a viral infection affecting the liver, poses...
-
Product Insights
NewLikelihood of Approval Analysis for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Overview How likely is it that the drugs in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. B-Cell Acute Lymphocytic Leukemia (B-Cell Acute...
-
Product Insights
NewLikelihood of Approval Analysis for Influenzavirus B Infections
Overview How likely is it that the drugs in Influenzavirus B Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Influenzavirus B Infections Overview Type B influenza is a subtype of...
-
Product Insights
NewLikelihood of Approval Analysis for B-Cell Leukemia
Overview How likely is it that the drugs in B-Cell Leukemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. B-Cell Leukemia Overview B-cell leukemia is a type of blood cancer that...
-
Product Insights
NewLikelihood of Approval Analysis for Marginal Zone B-cell Lymphoma
Overview How likely is it that the drugs in Marginal Zone B-cell Lymphoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Marginal Zone B-cell Lymphoma Overview Marginal zone B-cell lymphoma is...
-
Product Insights
NewLikelihood of Approval Analysis for Hemophilia B (Factor IX Deficiency)
Overview How likely is it that the drugs in Hemophilia B (Factor IX Deficiency) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hemophilia B (Factor IX Deficiency) Overview Hemophilia B is...
-
Product Insights
NewLikelihood of Approval Analysis for Primary Mediastinal B-Cell Lymphoma
Overview How likely is it that the drugs in Primary Mediastinal B-Cell Lymphoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Primary Mediastinal B-Cell Lymphoma Overview Primary Mediastinal B-Cell Lymphoma (PMBCL)...
-
Product Insights
NewLikelihood of Approval Analysis for Nodal Marginal Zone B-Cell Lymphoma
Overview How likely is it that the drugs in Nodal Marginal Zone B-Cell Lymphoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nodal Marginal Zone B-Cell Lymphoma Overview Nodal marginal zone...
-
Product Insights
NewLikelihood of Approval Analysis for Splenic Marginal Zone B-Cell Lymphoma
Overview How likely is it that the drugs in Splenic Marginal Zone B-Cell Lymphoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Splenic Marginal Zone B-Cell Lymphoma Overview Splenic marginal zone...
-
Product Insights
NewLikelihood of Approval Analysis for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
Overview How likely is it that the drugs in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Overview Hodgkin lymphoma is...